CVS agrees to pay $315 million to settle DOJ opioid prescription case
NBC News • • business
Key Points:
- CVS Pharmacy Inc. and its subsidiaries have agreed to pay $315 million to settle a Justice Department lawsuit alleging they unlawfully dispensed medically unnecessary opioid prescriptions.
- The 2024 lawsuit accused CVS of violating the Controlled Substances Act by filling prescriptions from "pill mills" and contributing to opioid addiction and overdose crises.
- The Justice Department stated that CVS's staffing levels and incentive policies pressured pharmacists to fill prescriptions without proper verification, often billing federal healthcare programs like Medicaid.
- Under the settlement, CVS must implement stronger safeguards to ensure opioids and controlled substances are only dispensed when medically appropriate.
- This settlement is part of a broader trend where drugmakers, wholesalers, and pharmacies have paid over $50 billion in related cases to address the opioid epidemic in the U.S.
